HSK-44459

N/A

Report date: 2026/05/26 20:00:28
NME

Base Information

Drug NameHSK-44459
Drug Alias NameHSK44459HSK-44459
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPhosphodiesterase 4B inhibitors
TargetsPhosphodiesterase 4B
Therapy Area/IndicationsPlaque psoriasisPsoriasisDermatitis, Atopic +[8] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesSichuan Haisco Pharmaceutical Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesTibet Haisco Pharmaceutical Co LtdShanghai Haisi Shengnuo Pharmaceutical Technology Co LtdSichuan Haisco Pharmaceutical Co Ltd +[4] 
Inactive CompaniesN/A
Active IndicationsPlaque psoriasisPsoriasisDermatitis, Atopic +[8] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A